tirzepatide surpass trials Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial Tirzepatide is finally here –

If oral contraceptives are your only contraceptive method, your healthcare provider may recommend adding a barrier method, such as condoms, during the first few weeks of treatment or when increasing your dose, or switching to a non-oral method, such as an IUD

Anyone on warfarin should not add berberine without INR monitoring and physician guidance

For adults and pediatric patients, subsequent dosages may be increased in case of an inadequate response in 25 to 50 mg per day increments once a week, depending on tolerability, up to a maximum of 200 mg per day

While appetite suppression facilitates weight loss, it creates a nutritional challenge

Understanding the Issue Ozempic, known generically as Semaglutide, is primarily prescribed to help manage type 2 diabetes and, in some cases, for weight management

Patients with A1C 8% at screening had their background basal insulin dose reduced by 20% at the start of the trial to limit potential risk of hypoglycemia